A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05160168 |
Recruitment Status :
Terminated
(The Sponsor terminated the study due to early dose-limiting toxicities.)
First Posted : December 16, 2021
Last Update Posted : April 12, 2024
|
Sponsor:
Theseus Pharmaceuticals
Information provided by (Responsible Party):
Theseus Pharmaceuticals
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | February 2, 2024 |
Actual Study Completion Date : | February 2, 2024 |
Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
---|---|---|
1 |
May 3, 2024 |